Notes
J ournal of Natural Products, 1998, Vol. 61, No. 9 1145
di-[{(2E)-3,7-dimethyl-2,6-octadienyl}oxy]-benzoate (8)
(130 mg, 18%): TLC (40% EtOAc-hexane) Rf 0.47 (dark
green with vanillin-H2SO4); anal. C 76.27%, H 9.35%,
calcd for C28H40O4, C 76.36%, H 9.09%; IR (film) 2920,
1720, 1596, 1514, 1438, 1267, 1208, 1132, 1009, 762
(3H, br s, H-8′), 1.77 (3H, d, J ) 1 Hz, 3′-Me), 2.09 (4H,
m, H-4′,5′), 3.89 (3H, s, 1-COOMe), 3.92 (3H, s, 4-OMe),
4.67 (2H, d, J ) 7 Hz, H-1′), 5.08 (1H, m, H-6′), 5.52
(1H, br t, J ) 7 Hz, H-2′), 6.88 (1H, d, J ) 8 Hz, H-5),
7.56 (1H, d, J ) 2 Hz, H-2), 7.67 (1H, dd, J ) 2, 8 Hz,
H-6); 13C NMR (CDCl3, 50 MHz) δ 16.7 (q, 3′-Me), 17.7
(q, 7′-Me), 25.7 (q, C-8′), 26.3 (t, C-5′), 39.7 (t, C-4′), 52.0
(q, 1-COOMe), 56.0 (q, 4-OMe), 65.9 (t, C-1′), 110.4 (d,
C-5), 113.8 (d, C-2), 119.3 (d, C-2′), 122.6 (s, C-1), 123.5
(d, C-6), 123.9 (d, C-6′), 131.8 (s, C-7′), 141.4 (s, C-3′),
147.9 (s, C-4), 153.4 (s, C-3), 167.0 (s, 1-COOMe).
Meth yl 4-[{(2E)-3,7-d im eth yl-5-oxo-2,6-octa d ien -
yl}oxy]-3-m eth oxyben zoa te (1). Pyridinium chloro-
chromate-alumina6 (1402 mg, 1.14 mmol) was added
to solution of 7 (127 mg, 0.38 mmol) in dry hexane (10
mL). After stirring for 24 h, the mixture was filtered
and washed with Et2O (3 × 10 mL). The combined Et2O
solutions were evaporated. Flash chromatography (elu-
tion with EtOAc-hexane 5:95) yielded 1 (37.8 mg, 30%),
1
cm-1; H NMR (CDCl3, 200 MHz) δ 1.59 (6H, br s, 7′-
Me), 1.66 (6H, br s, H-8′), 1.73/1.76 (each 3H, br s, 3′-
Me), 2.08 (8H, m, H-4′,5′), 3.87 (3H, s, 1-COOMe), 4.66/
4.69 (each 2H, d, J ) 8 Hz, H-1′), 5.08 (2H, m, H-6′),
5.50 (2H, br t, J ) 7 Hz, H-2′), 6.87 (1H, d, J ) 8 Hz,
H-5), 7.56 (1H, d, J ) 2 Hz, H-2), 7.63 (1H, dd, J ) 2, 9
Hz, H 6); 13C NMR (CDCl3, 50 MHz) δ 16.7 (2 × q, 3′-
Me), 17.7 (2 × q, 7′-Me), 25.6/26.2 (each q, C-8′), 26.2/
26.3 (each t, C-5′), 39.5/39.6 (each t, C-4′), 52.0, (q,
1-COOMe), 66.1 (2 x t, C-1′), 112.3 (d, C-5), 114.5 (d,
C-2), 119.5/119.6 (each d, C-2′), 122.4 (s, C-1), 123.5 (d,
C-6), 123.8/123.9 (each d, C-6′), 131.7/131.8 (each s,
C-7′), 140.7/140.8 (each s, C-3′), 148.2 (s, C-3), 152.9 (s,
C-4), 167.0 (s, 1-COOMe).
1
identical to the natural product (TLC, IR, H and 13C
Meth yl 3-[{(2E)-3,7-dim eth yl-2,6-octa dien yl}oxy]-
4-h yd r oxyben zoa te (9): methyl 3,4-dihydroxybenzoate
(278 mg, 1.65 mmol); geranyl bromide (358 mg, 1.65
mmol); NaH (60%, 66 mg, 1.65 mmol) in dry DMF (2
mL); 20 °C; 48 h; flash chromatography (5% EtOAc-
hexane) gave (8) (196 mg, 27%) and 9 (245 mg, 49%);
mp 34-37 °C; TLC (30% EtOAc-hexane) Rf 0.45 (dark
green with vanillin-H2SO4); anal. C 71.05%, H 7.89%,
calcd for C18H24O4, C 71.05%, H 7.89%; IR (film), 3388,
2921, 1709, 1595, 1512, 1438, 1286, 1211, 1126, 988,
NMR).1
Meth yla tion of 3 a n d 9. A mixture of K2CO3 (48.4
mg, 0.35 mmol), CH3I (26.0 mg, 0.18 mmol), and 3 (35.6
mg, 0.12 mmol) in DMF (1.0 mL) was stirred at 20 °C
for 17 h. The reaction mixture was diluted with H2O
and extracted with Et2O. The Et2O layer was washed
with H2O and saturated aqueous NaCl and the H2O
before drying over MgSO4 and evaporation. Preparative
TLC gave 2 (20 mg, 54%). Likewise, reaction of 9 (90
mg) gave 2 (50 mg, 50.4%).
1
764 cm-1; H NMR (CDCl3, 200 MHz) δ 1.62 (3H, br s,
7′-Me), 1.68 (3H, br s, H-8′), 1.77 (3H, br s, 3′-Me), 2.11
(4H, m, H-4′,5′), 3.89 (3H, s, COOMe), 4.66 (2H, d, J )
7 Hz, H-1′), 5.09 (1H, m, H-6′), 5.49 (1H, br t, J ) 7 Hz,
H-2′), 6.12 (1H, s, 4-OH), 6.94 (1H, d, J ) 8 Hz, H-5),
7.57 (1H, d, J ) 2 Hz, H-2), 7.63 (1H, dd, J ) 2, 8 Hz,
H-6); 13C NMR (CDCl3, 50 MHz) δ 16.7 (q, 3′-Me), 17.8
(q, 7′-Me), 25.7 (q, C-8′), 26.3 (t, C-5′), 39.6 (t, C-4′), 52.0
(q, 1-COOMe), 66.0 (t, C-1′), 113.1 (d, C-5), 114.1 (d, C-2),
118.6 (d, C-2′), 122.8 (s, C-1), 123.7 (d, C-6), 124.1 (d,
C-6′), 132.0 (s C-7′), 142.7 (s, C-3′), 145.5 (s, C-4), 150.4
(s, C-3), 167.0 (s, 1-COOMe).
Ack n ow led gm en t. We thank B. May for prelimi-
nary work; E. Sausville, U.S. National Cancer Institute
for AIDS-related lymphoma results; M. Thomas for
NMR spectra; and R. Cunninghame and associates for
microanalyses. This research was supported in part by
both the New Zealand Foundation for Research, Science
and Technology and Wonkwang University.
Refer en ces a n d Notes
(1) Perry, N. B.; Foster, L. M.; Lorimer, S. D.; May, B. C. H.;
Weavers, R. T.; Toyota, M.; Nakaishi, E.; Asakawa, Y. J . Nat.
Prod. 1996, 59, 729-733.
Meth yl 3-[{(2E)-3,7-dim eth yl-2,6-octa dien yl}oxy]-
4-m eth yoxyben zoa te (10): methyl 3-hydroxy-4-meth-
oxybenzoate (1230 mg, 6.76 mmol); geranyl bromide
(1779 mg, 8.19 mmol); NaH (60%, 295 mg, 7.37 mmol)
in dry DMF (8.2 mL); 20 °C; 26 h; flash chromatography
(3% EtOAc-hexane) gave 10 (1503 mg, 70%) (14); mp
40-42 °C; TLC (30% EtOAc-hexane) Rf 0.36 (green
with vanillin-H2SO4); anal. C 71.43%, H 8.17%, calcd
for C19H26O4, C 71.70%, H 8.18%; IR (Nujol) 1720, 1594,
(2) 50% growth inhibition values range from 9.7 × 10-9 to 2.5 ×
10-5 M.; see Skehan, P.; Williamson, K.; Giavazzi, R.; Malspeis,
L.; Camalier, R.; Grever, M. Proc. Annu. Meet. Am. Assoc. Cancer
Res. 1993, 34 (4), A2600.
(3) Baek, S.-H.; Perry, N. B.; Weavers, R. T.; Tangney, R. S. J . Nat.
Prod. 1998, 61, 126-129.
(4) Bergman, J .; Venemalm, L. Tetrahedron Lett. 1987, 28, 3741-
3744.
(5) Adams, D. R.; Bhatnagar, S. P.; Cookson, R. C.; Tuddenham, R.
M. J . Chem. Soc., Perkin Trans. 1 1975, 1741-1743.
(6) Cheng, Y.-S.; Liu, W.-L.; Chen, S.-H. Synthesis 1980, 223-224.
1513, 1463, 1376, 1267, 1218, 1131, 1011, 835, 726 cm-1
1H NMR (CDCl3, 300 MHz) δ 1.60 (3H, br s, 7′-Me), 1.66
;
NP980031W